Atea Pharmaceuticals Inc
NASDAQ:AVIR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Atea Pharmaceuticals Inc
NASDAQ:AVIR
|
US |
|
WEG SA
BOVESPA:WEGE3
|
BR |
|
HIAG Immobilien Holding AG
SIX:HIAG
|
CH |
|
Warehouse Group Ltd
NZX:WHS
|
NZ |
|
RGC Resources Inc
NASDAQ:RGCO
|
US |
|
Sands China Ltd
HKEX:1928
|
MO |
|
Deutsche Post AG
OTC:DHLGY
|
DE |
|
P
|
Pernod Ricard SA
SWB:PER
|
FR |
|
Ebusco Holding NV
AEX:EBUS
|
NL |
|
IZEA Worldwide Inc
NASDAQ:IZEA
|
US |
|
V
|
Veolia Environnement SA
OTC:VEOEY
|
FR |
|
B
|
Biotest AG
XETRA:BIO2
|
DE |
|
H
|
Hartford Financial Services Group Inc
F:HFF
|
US |
|
Touchstone Exploration Inc
TSX:TXP
|
CA |
|
S
|
Siam Global House PCL
SET:GLOBAL
|
TH |
|
B
|
Bangkok Commercial Asset Management PCL
SET:BAM
|
TH |
|
S
|
Swire Pacific Ltd
OTC:SWRAY
|
HK |
|
NeuPath Health Inc
XTSX:NPTH
|
CA |
|
Bourse Direct SA
F:BD6
|
FR |
|
SEB SA
PAR:SK
|
FR |
|
Rashtriya Chemicals and Fertilizers Ltd
NSE:RCF
|
IN |
|
T
|
Tencent Music Entertainment Group
HKEX:1698
|
CN |
|
F
|
F5 Inc
SWB:FFV
|
US |
Wall St Price Targets
AVIR Price Targets Summary
Atea Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
AVIR is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AVIR's stock price target?
Price Target
10.2
USD
According to Wall Street analysts, the average 1-year price target for
AVIR is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.